Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

The risk environments of people who use drugs accessing two harm reduction centers in Tehran, Iran: A qualitative study.

Bastani P, Marshall BDL, Rahimi-Movaghar A, Noroozi A.

Int J Drug Policy. 2018 Dec 1;63:90-96. doi: 10.1016/j.drugpo.2018.11.013. [Epub ahead of print]

PMID:
30513474
2.

Comparing Injecting Risk Behaviors of Long-Term Injectors with New Injectors in Tehran, Iran.

Bazrafshan MR, Noroozi M, Ghisvand H, Noroozi A, Alibeigi N, Abbasi M, Higgs P, Armoon B.

Subst Use Misuse. 2018 Nov 26:1-6. doi: 10.1080/10826084.2018.1491055. [Epub ahead of print]

PMID:
30474470
3.

Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.

Noroozi M, Noroozi A, Sharifi H, Harouni GG, Marshall BDL, Ghisvand H, Qorbani M, Armoon B.

Int J Behav Med. 2018 Nov 20. doi: 10.1007/s12529-018-9758-4. [Epub ahead of print]

PMID:
30460445
4.

Effect of Alcohol Use on Injection and Sexual Behavior among People Who Inject Drugs in Tehran, Iran: A Coarsened Exact Matching Approach.

Noroozi M, Marshall BDL, Noroozi A, Armoon B, Sharifi H, Qorbani M, Abbasi M, Bazrafshan MR.

J Res Health Sci. 2018 May 19;18(2):e00416.

5.

Self-Reported and Network Scale-Up Estimates of Substance Use Prevalence among University Students in Kerman, Iran.

Zahedi R, Noroozi A, Hajebi A, Haghdoost AA, Baneshi MR, Sharifi H, Mirzazadeh A.

J Res Health Sci. 2018 Apr 30;18(2):e00413.

6.

Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran.

Noroozi M, Armoon B, Ghisvand H, Noroozi A, Karimy M, Bazrafshan MR, Marshall BDL, Dieji B.

J Cosmet Dermatol. 2018 May 20. doi: 10.1111/jocd.12675. [Epub ahead of print]

PMID:
29781249
7.

Lead poisoning outbreak among opium users in the Islamic Republic of Iran, 2016-2017.

Ghane T, Zamani N, Hassanian-Moghaddam H, Beyrami A, Noroozi A.

Bull World Health Organ. 2018 Mar 1;96(3):165-172. doi: 10.2471/BLT.17.196287. Epub 2018 Feb 5.

8.

Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study.

Noroozi A, Malekinejad M, Rahimi-Movaghar A.

J Psychoactive Drugs. 2018 Jul-Aug;50(3):214-223. doi: 10.1080/02791072.2018.1425808. Epub 2018 Jan 29.

PMID:
29377788
9.

Cost-effectiveness of Methadone Maintenance Treatment Centers in Prevention of Human Immunodeficiency Virus Infection.

Pourkhajoei S, Barouni M, Noroozi A, Hajebi A, Amini S, Karamouzian M, Sharifi H.

Addict Health. 2017 Apr;9(2):81-87.

10.

Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.

Noroozi M, Marshall BDL, Noroozi A, Armoon B, Sharifi H, Farhoudian A, Ghiasvand H, Vameghi M, Rezaei O, Sayadnasiri M, Pouya RH.

Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S303-S308. doi: 10.1111/dar.12646. Epub 2017 Dec 21.

PMID:
29271013
11.

Decomposition of Economic Inequality in Needle and Syringe Programs Utilization to its Determinants among Men Who Inject Drugs in Tehran using Blinder-Oaxaca Decomposition Method.

Noroozi M, Rahimi E, Ghisvand H, Qorbani M, Sharifi H, Noroozi A, Farhoudian A, Marshall BDL, Jorjoran Shoshtari Z, Karimi SE, Rezaei O, Armoon B.

Subst Use Misuse. 2018 Jun 7;53(7):1170-1176. doi: 10.1080/10826084.2017.1400567. Epub 2017 Nov 22.

PMID:
29166171
12.

Cognitive rehabilitation for individuals with opioid use disorder: A randomized controlled trial.

Rezapour T, Hatami J, Farhoudian A, Sofuoglu M, Noroozi A, Daneshmand R, Samiei A, Ekhtiari H.

Neuropsychol Rehabil. 2017 Nov 21:1-17. doi: 10.1080/09602011.2017.1391103. [Epub ahead of print]

PMID:
29161998
13.

Decomposing economic disparities in risky sexual behaviors among people who inject drugs in Tehran: Blinder-Oaxaca decomposition analysis.

Noroozi M, Sharifi H, Noroozi A, Rezaei F, Bazrafshan MR, Armoon B.

Epidemiol Health. 2017 Nov 5;39:e2017049. doi: 10.4178/epih.e2017049. eCollection 2017.

14.

Lead Poisoning among Opium Users in Iran: A Possible New Emerging Epidemic in the Region.

Radfar SR, Nematollahi P, Farhoudian A, Noroozi A.

Iran J Public Health. 2017 Aug;46(8):1152-1153. No abstract available.

15.

Injecting and Sexual Networks and Sociodemographic Factors and Dual HIV Risk among People Who Inject Drugs: A Cross-sectional Study in Kermanshah Province, Iran.

Noroozi M, Mirzazadeh A, Noroozi A, Sharifi H, Higgs P, Jorjoran-Shushtari Z, Farhoudian A, Fadai F, Mohhamadi-Shahboulaghi F, Armoon B, Hajebi A, Massah O.

Addict Health. 2016 Jul;8(3):186-194.

16.

Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004-2015: a review.

Shadloo B, Amin-Esmaeili M, Haft-Baradaran M, Noroozi A, Ghorban-Jahromi R, Rahimi-Movaghar A.

East Mediterr Health J. 2017 May 1;23(3):245-256. Review.

PMID:
28493273
17.

Comparing Characteristics of Early-Onset Injection Drug Users to Those With Late-Onset Injection in Kermanshah, Iran.

Jorjoran Shushtari Z, Noroozi A, Mirzazadeh A, Ahounbar E, Hajbi A, Najafi M, Bazrafshan A, Farhadi MH, Farhoudian A, Higgs P, Shahboulagh FM, Waye K, Noroozi M.

Subst Use Misuse. 2017 May 12;52(6):754-759. doi: 10.1080/10826084.2016.1263666. Epub 2017 Feb 3.

PMID:
28157414
18.

Patterns of HIV Risks and Related Factors among People Who Inject Drugs in Kermanshah, Iran: A Latent Class Analysis.

Sharifi H, Mirzazadeh A, Noroozi A, Marshall BD, Farhoudian A, Higgs P, Vameghi M, Mohhamadi Shahboulaghi F, Qorbani M, Massah O, Armoon B, Noroozi M.

J Psychoactive Drugs. 2017 Jan-Mar;49(1):69-73. doi: 10.1080/02791072.2016.1262568. Epub 2016 Dec 12.

19.

Impact of HIV Status Notification on Risk Behaviors among Men Who Inject Drugs in Kermanshah, West of Iran.

Noroozi A, Mirzazadeh A, Farhoudian A, Hajebi A, Khankeh HR, Higgs P, Sharifi H, Armoon B, Noroozi M.

J Res Health Sci. 2016 Summer;16(3):116-121.

20.

Inpatient Opioid Withdrawal Management of Street Children and Adolescents Admitted to Child and Adolescent Psychiatric Ward: A Preliminary Case Series.

Firouzkouhi Moghadam M, Hashemian SS, Pishjoo M, Ghasemi S, Hajebi A, Noroozi A.

Iran J Pediatr. 2016 Jul 13;26(4):e5133. eCollection 2016 Aug.

21.

Impulsivity, Sensation Seeking, and Risk-Taking Behaviors among HIV-Positive and HIV-Negative Heroin Dependent Persons.

Paydary K, Mahin Torabi S, SeyedAlinaghi S, Noori M, Noroozi A, Ameri S, Ekhtiari H.

AIDS Res Treat. 2016;2016:5323256. doi: 10.1155/2016/5323256. Epub 2016 Mar 8.

22.

Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran.

Noroozi M, Mirzazadeh A, Noroozi A, Mehrabi Y, Hajebi A, Zamani S, Sharifi H, Higgs P, Soori H.

Addict Health. 2015 Summer-Autumn;7(3-4):164-73.

23.

Effectiveness of Mindfulness-Based Group Therapy Compared to the Usual Opioid Dependence Treatment.

Imani S, Atef Vahid MK, Gharraee B, Noroozi A, Habibi M, Bowen S.

Iran J Psychiatry. 2015 Jun;10(3):175-84.

24.

Integration of outpatient alcohol treatment services in substance abuse treatment centers: An introduction to the first national program in Iran.

Shariatirad S, Massah O, Farhoudian A, Radfar SR, Molavi N, Hashemian SS, Daneshmand R, Noroozi A.

Int J Drug Policy. 2016 Mar;29:100-1. doi: 10.1016/j.drugpo.2015.12.003. Epub 2015 Dec 23. No abstract available.

PMID:
26790690
25.

The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.

Nazari SS, Noroozi M, Soori H, Noroozi A, Mehrabi Y, Hajebi A, Sharifi H, Higgs P, Mirzazadeh A.

Int J Drug Policy. 2016 Jan;27:127-31. doi: 10.1016/j.drugpo.2015.10.011. Epub 2015 Nov 12.

PMID:
26764125
26.

NEuro COgnitive REhabilitation for Disease of Addiction (NECOREDA) Program: From Development to Trial.

Rezapour T, Hatami J, Farhoudian A, Sofuoglu M, Noroozi A, Daneshmand R, Samiei A, Ekhtiari H.

Basic Clin Neurosci. 2015 Oct;6(4):291-8.

27.

High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Malekinejad M, Navadeh S, Lotfizadeh A, Rahimi-Movaghar A, Amin-Esmaeili M, Noroozi A.

Int J Infect Dis. 2015 Nov;40:116-30. doi: 10.1016/j.ijid.2015.09.022. Epub 2015 Oct 13. Review.

28.

Comparing Mindfulness-Based Group Therapy With Treatment as Usual for Opioid Dependents: A Pilot Randomized Clinical Trial Study Protocol.

Imani S, Atef Vahid MK, Gharraee B, Habibi M, Bowen S, Noroozi A.

Iran J Psychiatry Behav Sci. 2015 Mar;9(1):e216. doi: 10.17795/ijpbs216. Epub 2015 Mar 7.

29.

Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence.

Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M.

Int J Drug Policy. 2015 Sep;26(9):808-19. doi: 10.1016/j.drugpo.2015.04.018. Epub 2015 May 12. Review.

31.

Effects of cold environments on human reliability assessment in offshore oil and gas facilities.

Noroozi A, Abbassi R, MacKinnon S, Khan F, Khakzad N.

Hum Factors. 2014 Aug;56(5):825-39.

PMID:
25141591
32.

Methamphetamine use among Iranian heroin kerack-dependent women: implications for treatment.

Alam Mehrjerdi Z, Abarashi Z, Mansoori S, Deylamizadeh A, Salehi Fadardi J, Noroozi A, Zarghami M.

Int J High Risk Behav Addict. 2013 Jun;2(1):15-21. doi: 10.5812/ijhrba.10216. Epub 2013 Jun 26.

33.

Methamphetamine intoxication in emergency departments of hospitals in iran: implications for treatment.

Alam Mehrjerdi Z, Noroozi A.

Iran J Med Sci. 2013 Dec;38(4):347-8. No abstract available.

34.

Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran.

Mehrjerdi ZA, Abarashi Z, Noroozi A, Arshad L, Zarghami M.

Int J STD AIDS. 2014 May;25(6):420-7. doi: 10.1177/0956462413512806. Epub 2013 Nov 28.

PMID:
24287028
35.

An emerging trend of methamphetamine injection in iran: a critical target for research on blood-borne infection diseases.

Alam Mehrjerdi Z, Noroozi A.

Hepat Mon. 2013 Feb 28;13(2):e8154. doi: 10.5812/hepatmon.8154. Print 2013 Feb. No abstract available.

36.

Senior medical students' attitudes toward psychiatry as a career choice before and after an undergraduate psychiatry internship in Iran.

Amini H, Moghaddam Y, Nejatisafa AA, Esmaeili S, Kaviani H, Shoar S, Shabani A, Samimi-Ardestani M, Akhlaghi AA, Noroozi A, Mafi M.

Acad Psychiatry. 2013 May 1;37(3):196-201. doi: 10.1176/appi.ap.10120171.

PMID:
23632933
37.

Methamphetamine-associated psychosis: a new health challenge in Iran.

Alam Mehrjerdi Z, Barr AM, Noroozi A.

Daru. 2013 Apr 11;21(1):30. doi: 10.1186/2008-2231-21-30.

38.

Outbreak of exogenous Cushing's syndrome due to unlicensed medications.

Azizi F, Jahed A, Hedayati M, Lankarani M, Bejestani HS, Esfahanian F, Beyraghi N, Noroozi A, Kobarfard F.

Clin Endocrinol (Oxf). 2008 Dec;69(6):921-5. doi: 10.1111/j.1365-2265.2008.03290.x. Epub 2008 May 6.

PMID:
18462262

Supplemental Content

Loading ...
Support Center